Vascular	0	8	B-Gene_or_gene_product
endothelial	9	20	I-Gene_or_gene_product
growth	21	27	I-Gene_or_gene_product
factor	28	34	I-Gene_or_gene_product
-	34	35	I-Gene_or_gene_product
B	35	36	I-Gene_or_gene_product
and	37	40	O
vascular	41	49	B-Gene_or_gene_product
endothelial	50	61	I-Gene_or_gene_product
growth	62	68	I-Gene_or_gene_product
factor	69	75	I-Gene_or_gene_product
-	75	76	I-Gene_or_gene_product
C	76	77	I-Gene_or_gene_product
expression	78	88	O
in	89	91	O
renal	92	97	B-Pathological_formation
cell	98	102	I-Pathological_formation
carcinomas	103	113	I-Pathological_formation
:	113	114	O
regulation	115	125	O
by	126	128	O
the	129	132	O
von	133	136	B-Gene_or_gene_product
Hippel	137	143	I-Gene_or_gene_product
-	143	144	I-Gene_or_gene_product
Lindau	144	150	I-Gene_or_gene_product
gene	151	155	O
and	156	159	O
hypoxia	160	167	O
.	167	168	O

Angiogenesis	170	182	O
is	183	185	O
essential	186	195	O
for	196	199	O
tumor	200	205	B-Pathological_formation
growth	206	212	O
and	213	216	O
metastasis	217	227	O
.	227	228	O

It	229	231	O
is	232	234	O
regulated	235	244	O
by	245	247	O
numerous	248	256	O
angiogenic	257	267	O
factors	268	275	O
,	275	276	O
one	277	280	O
of	281	283	O
the	284	287	O
most	288	292	O
important	293	302	O
being	303	308	O
vascular	309	317	B-Gene_or_gene_product
endothelial	318	329	I-Gene_or_gene_product
growth	330	336	I-Gene_or_gene_product
factor	337	343	I-Gene_or_gene_product
(	344	345	O
VEGF	345	349	B-Gene_or_gene_product
)	349	350	O
.	350	351	O

Recently	352	360	O
VEGF	361	365	B-Gene_or_gene_product
-	365	366	I-Gene_or_gene_product
B	366	367	I-Gene_or_gene_product
and	368	371	O
VEGF	372	376	B-Gene_or_gene_product
-	376	377	I-Gene_or_gene_product
C	377	378	I-Gene_or_gene_product
,	378	379	O
two	380	383	O
new	384	387	O
VEGF	388	392	B-Gene_or_gene_product
family	393	399	O
members	400	407	O
,	407	408	O
have	409	413	O
been	414	418	O
identified	419	429	O
that	430	434	O
bind	435	439	O
to	440	442	O
the	443	446	O
tyrosine	447	455	O
kinase	456	462	O
receptors	463	472	O
flt	473	476	B-Gene_or_gene_product
-	476	477	I-Gene_or_gene_product
1	477	478	I-Gene_or_gene_product
(	479	480	O
VEGFR1	480	486	B-Gene_or_gene_product
)	486	487	O
,	487	488	O
KDR	489	492	B-Gene_or_gene_product
(	493	494	O
VEGFR2	494	500	B-Gene_or_gene_product
)	500	501	O
,	501	502	O
and	503	506	O
flt	507	510	B-Gene_or_gene_product
-	510	511	I-Gene_or_gene_product
4	511	512	I-Gene_or_gene_product
(	513	514	O
VEGFR3	514	520	B-Gene_or_gene_product
)	520	521	O
.	521	522	O

Although	523	531	O
the	532	535	O
importance	536	546	O
of	547	549	O
VEGF	550	554	B-Gene_or_gene_product
-	554	555	I-Gene_or_gene_product
A	555	556	I-Gene_or_gene_product
has	557	560	O
been	561	565	O
shown	566	571	O
in	572	574	O
renal	575	580	B-Pathological_formation
carcinomas	581	591	I-Pathological_formation
,	591	592	O
the	593	596	O
contribution	597	609	O
of	610	612	O
these	613	618	O
new	619	622	O
ligands	623	630	O
in	631	633	O
kidney	634	640	B-Pathological_formation
tumors	641	647	I-Pathological_formation
is	648	650	O
not	651	654	O
clear	655	660	O
.	660	661	O

We	662	664	O
have	665	669	O
,	669	670	O
therefore	671	680	O
,	680	681	O
measured	682	690	O
the	691	694	O
mRNA	695	699	O
level	700	705	O
of	706	708	O
VEGF	709	713	B-Gene_or_gene_product
-	713	714	I-Gene_or_gene_product
B	714	715	I-Gene_or_gene_product
and	716	719	O
VEGF	720	724	B-Gene_or_gene_product
-	724	725	I-Gene_or_gene_product
C	725	726	I-Gene_or_gene_product
together	727	735	O
with	736	740	O
their	741	746	O
receptors	747	756	O
by	757	759	O
RNase	760	765	B-Gene_or_gene_product
protection	766	776	O
assay	777	782	O
(	783	784	O
RPA	784	787	O
)	787	788	O
in	789	791	O
26	792	794	O
normal	795	801	B-Multi-tissue_structure
kidney	802	808	I-Multi-tissue_structure
samples	809	816	I-Multi-tissue_structure
and	817	820	O
45	821	823	O
renal	824	829	B-Pathological_formation
cell	830	834	I-Pathological_formation
cancers	835	842	I-Pathological_formation
.	842	843	O

We	844	846	O
observed	847	855	O
a	856	857	O
significant	858	869	O
up	870	872	O
-	872	873	O
regulation	873	883	O
of	884	886	O
VEGF	887	891	B-Gene_or_gene_product
-	891	892	I-Gene_or_gene_product
B	892	893	I-Gene_or_gene_product
(	894	895	O
P	895	896	O
=	897	898	O
0	899	900	O
.	900	901	O
002	901	904	O
)	904	905	O
but	906	909	O
not	910	913	O
VEGF	914	918	B-Gene_or_gene_product
-	918	919	I-Gene_or_gene_product
C	919	920	I-Gene_or_gene_product
(	921	922	O
P	922	923	O
=	924	925	O
0	926	927	O
.	927	928	O
3	928	929	O
)	929	930	O
in	931	933	O
neoplastic	934	944	B-Organ
kidney	945	951	I-Organ
compared	952	960	O
with	961	965	O
normal	966	972	B-Tissue
tissues	973	980	I-Tissue
.	980	981	O

In	982	984	O
addition	985	993	O
,	993	994	O
although	995	1003	O
VEGF	1004	1008	B-Gene_or_gene_product
receptors	1009	1018	I-Gene_or_gene_product
were	1019	1023	O
higher	1024	1030	O
in	1031	1033	O
tumors	1034	1040	B-Pathological_formation
than	1041	1045	O
normal	1046	1052	O
kidney	1053	1059	B-Organ
,	1059	1060	O
there	1061	1066	O
was	1067	1070	O
a	1071	1072	O
significant	1073	1084	O
up	1085	1087	O
-	1087	1088	O
regulation	1088	1098	O
of	1099	1101	O
only	1102	1106	O
flt	1107	1110	B-Gene_or_gene_product
-	1110	1111	I-Gene_or_gene_product
1	1111	1112	I-Gene_or_gene_product
(	1113	1114	O
P	1114	1115	O
=	1116	1117	O
0	1118	1119	O
.	1119	1120	O
003	1120	1123	O
)	1123	1124	O
but	1125	1128	O
not	1129	1132	O
KDR	1133	1136	B-Gene_or_gene_product
(	1137	1138	O
P	1138	1139	O
=	1140	1141	O
0	1142	1143	O
.	1143	1144	O
12	1144	1146	O
)	1146	1147	O
or	1148	1150	O
flt	1151	1154	B-Gene_or_gene_product
-	1154	1155	I-Gene_or_gene_product
4	1155	1156	I-Gene_or_gene_product
(	1157	1158	O
P	1158	1159	O
=	1160	1161	O
0	1162	1163	O
.	1163	1164	O
09	1164	1166	O
)	1166	1167	O
.	1167	1168	O

There	1169	1174	O
was	1175	1178	O
also	1179	1183	O
a	1184	1185	O
significant	1186	1197	O
correlation	1198	1209	O
between	1210	1217	O
VEGF	1218	1222	B-Gene_or_gene_product
-	1222	1223	I-Gene_or_gene_product
C	1223	1224	I-Gene_or_gene_product
and	1225	1228	O
both	1229	1233	O
of	1234	1236	O
its	1237	1240	O
receptors	1241	1250	O
flt	1251	1254	B-Gene_or_gene_product
-	1254	1255	I-Gene_or_gene_product
4	1255	1256	I-Gene_or_gene_product
(	1257	1258	O
P	1258	1259	O
=	1260	1261	O
0	1262	1263	O
.	1263	1264	O
006	1264	1267	O
)	1267	1268	O
and	1269	1272	O
KDR	1273	1276	B-Gene_or_gene_product
(	1277	1278	O
P	1278	1279	O
=	1280	1281	O
0	1282	1283	O
.	1283	1284	O
03	1284	1286	O
)	1286	1287	O
but	1288	1291	O
no	1292	1294	O
association	1295	1306	O
between	1307	1314	O
VEGF	1315	1319	B-Gene_or_gene_product
-	1319	1320	I-Gene_or_gene_product
B	1320	1321	I-Gene_or_gene_product
and	1322	1325	O
its	1326	1329	O
receptor	1330	1338	O
flt	1339	1342	B-Gene_or_gene_product
-	1342	1343	I-Gene_or_gene_product
1	1343	1344	I-Gene_or_gene_product
(	1345	1346	O
P	1346	1347	O
=	1348	1349	O
0	1350	1351	O
.	1351	1352	O
23	1352	1354	O
)	1354	1355	O
.	1355	1356	O

A	1357	1358	O
significant	1359	1370	O
increase	1371	1379	O
was	1380	1383	O
observed	1384	1392	O
in	1393	1395	O
flt	1396	1399	B-Gene_or_gene_product
-	1399	1400	I-Gene_or_gene_product
1	1400	1401	I-Gene_or_gene_product
(	1402	1403	O
P	1403	1404	O
less	1406	1410	O
than	1411	1415	O
0	1417	1418	O
.	1418	1419	O
001	1419	1422	O
)	1422	1423	O
,	1423	1424	O
KDR	1425	1428	B-Gene_or_gene_product
(	1429	1430	O
P	1430	1431	O
=	1432	1433	O
0	1434	1435	O
.	1435	1436	O
02	1436	1438	O
)	1438	1439	O
,	1439	1440	O
and	1441	1444	O
flt	1445	1448	B-Gene_or_gene_product
-	1448	1449	I-Gene_or_gene_product
4	1449	1450	I-Gene_or_gene_product
(	1451	1452	O
P	1452	1453	O
=	1454	1455	O
0	1456	1457	O
.	1457	1458	O
01	1458	1460	O
)	1460	1461	O
but	1462	1465	O
not	1466	1469	O
VEGF	1470	1474	B-Gene_or_gene_product
-	1474	1475	I-Gene_or_gene_product
B	1475	1476	I-Gene_or_gene_product
(	1477	1478	O
P	1478	1479	O
=	1480	1481	O
0	1482	1483	O
.	1483	1484	O
82	1484	1486	O
)	1486	1487	O
or	1488	1490	O
VEGF	1491	1495	B-Gene_or_gene_product
-	1495	1496	I-Gene_or_gene_product
C	1496	1497	I-Gene_or_gene_product
(	1498	1499	O
P	1499	1500	O
=	1501	1502	O
0	1503	1504	O
.	1504	1505	O
52	1505	1507	O
)	1507	1508	O
expression	1509	1519	O
in	1520	1522	O
clear	1523	1528	B-Cell
cell	1529	1533	I-Cell
compared	1534	1542	O
with	1543	1547	O
chromophil	1548	1558	B-Pathological_formation
(	1559	1560	I-Pathological_formation
papillary	1560	1569	I-Pathological_formation
)	1569	1570	I-Pathological_formation
carcinomas	1571	1581	I-Pathological_formation
.	1581	1582	O

No	1583	1585	O
significant	1586	1597	O
association	1598	1609	O
was	1610	1613	O
demonstrated	1614	1626	O
between	1627	1634	O
VEGF	1635	1639	B-Gene_or_gene_product
-	1639	1640	I-Gene_or_gene_product
B	1640	1641	I-Gene_or_gene_product
,	1641	1642	O
VEGF	1643	1647	B-Gene_or_gene_product
-	1647	1648	I-Gene_or_gene_product
C	1648	1649	I-Gene_or_gene_product
,	1649	1650	O
flt	1651	1654	B-Gene_or_gene_product
-	1654	1655	I-Gene_or_gene_product
1	1655	1656	I-Gene_or_gene_product
,	1656	1657	O
KDR	1658	1661	B-Gene_or_gene_product
,	1661	1662	O
and	1663	1666	O
flt	1667	1670	B-Gene_or_gene_product
-	1670	1671	I-Gene_or_gene_product
4	1671	1672	I-Gene_or_gene_product
with	1673	1677	O
patient	1678	1685	B-Organism
sex	1686	1689	O
,	1689	1690	O
patient	1691	1698	B-Organism
age	1699	1702	O
,	1702	1703	O
or	1704	1706	O
tumor	1707	1712	B-Pathological_formation
size	1713	1717	O
(	1718	1719	O
P	1719	1720	O
greater	1722	1729	O
than	1730	1734	O
0	1736	1737	O
.	1737	1738	O
05	1738	1740	O
)	1740	1741	O
.	1741	1742	O

The	1743	1746	O
effect	1747	1753	O
of	1754	1756	O
von	1757	1760	B-Gene_or_gene_product
Hippel	1761	1767	I-Gene_or_gene_product
-	1767	1768	I-Gene_or_gene_product
Lindau	1768	1774	I-Gene_or_gene_product
(	1775	1776	O
VHL	1776	1779	B-Gene_or_gene_product
)	1779	1780	O
gene	1781	1785	O
and	1786	1789	O
hypoxia	1790	1797	O
on	1798	1800	O
VEGF	1801	1805	B-Gene_or_gene_product
-	1805	1806	I-Gene_or_gene_product
B	1806	1807	I-Gene_or_gene_product
and	1808	1811	O
VEGF	1812	1816	B-Gene_or_gene_product
-	1816	1817	I-Gene_or_gene_product
C	1817	1818	I-Gene_or_gene_product
expression	1819	1829	O
in	1830	1832	O
the	1833	1836	O
renal	1837	1842	B-Pathological_formation
carcinoma	1843	1852	I-Pathological_formation
cell	1853	1857	O
line	1858	1862	O
786	1863	1866	B-Cell
-	1866	1867	I-Cell
0	1867	1868	I-Cell
transfected	1869	1880	O
with	1881	1885	O
wild	1886	1890	O
-	1890	1891	O
type	1891	1895	O
and	1896	1899	O
mutant	1900	1906	O
VHL	1907	1910	B-Gene_or_gene_product
was	1911	1914	O
determined	1915	1925	O
by	1926	1928	O
growing	1929	1936	O
cells	1937	1942	B-Cell
under	1943	1948	O
21	1949	1951	O
%	1951	1952	O
O2	1953	1955	O
-	1955	1956	O
and	1957	1960	O
0	1961	1962	O
.	1962	1963	O
1	1963	1964	O
%	1964	1965	O
O2	1966	1968	O
.	1968	1969	O

In	1970	1972	O
wild	1973	1977	O
-	1977	1978	O
type	1978	1982	O
VHL	1983	1986	B-Gene_or_gene_product
cells	1987	1992	O
,	1992	1993	O
whereas	1994	2001	O
VEGF	2002	2006	B-Gene_or_gene_product
-	2006	2007	I-Gene_or_gene_product
A	2007	2008	I-Gene_or_gene_product
was	2009	2012	O
significantly	2013	2026	O
up	2027	2029	O
-	2029	2030	O
regulated	2030	2039	O
under	2040	2045	O
hypoxic	2046	2053	O
compared	2054	2062	O
with	2063	2067	O
normoxic	2068	2076	O
conditions	2077	2087	O
(	2088	2089	O
P	2089	2090	O
less	2092	2096	O
than	2097	2101	O
0	2103	2104	O
.	2104	2105	O
001	2105	2108	O
)	2108	2109	O
,	2109	2110	O
expression	2111	2121	O
of	2122	2124	O
VEGF	2125	2129	B-Gene_or_gene_product
-	2129	2130	I-Gene_or_gene_product
C	2130	2131	I-Gene_or_gene_product
was	2132	2135	O
reduced	2136	2143	O
(	2144	2145	O
P	2145	2146	O
less	2148	2152	O
than	2153	2157	O
0	2159	2160	O
.	2160	2161	O
002	2161	2164	O
)	2164	2165	O
.	2165	2166	O

Nevertheless	2167	2179	O
,	2179	2180	O
the	2181	2184	O
repression	2185	2195	O
of	2196	2198	O
VEGF	2199	2203	B-Gene_or_gene_product
-	2203	2204	I-Gene_or_gene_product
C	2204	2205	I-Gene_or_gene_product
was	2206	2209	O
lost	2210	2214	O
in	2215	2217	O
mutant	2218	2224	O
VHL	2225	2228	B-Gene_or_gene_product
cell	2229	2233	O
lines	2234	2239	O
under	2240	2245	O
hypoxia	2246	2253	O
.	2253	2254	O

In	2255	2257	O
contrast	2258	2266	O
VEGF	2267	2271	B-Gene_or_gene_product
-	2271	2272	I-Gene_or_gene_product
B	2272	2273	I-Gene_or_gene_product
was	2274	2277	O
not	2278	2281	O
regulated	2282	2291	O
by	2292	2294	O
VHL	2295	2298	B-Gene_or_gene_product
despite	2299	2306	O
clear	2307	2312	O
up	2313	2315	O
-	2315	2316	O
regulation	2316	2326	O
in	2327	2329	O
vivo	2330	2334	O
.	2334	2335	O

These	2336	2341	O
findings	2342	2350	O
strongly	2351	2359	O
support	2360	2367	O
an	2368	2370	O
enhanced	2371	2379	O
role	2380	2384	O
for	2385	2388	O
this	2389	2393	O
pathway	2394	2401	O
in	2402	2404	O
clear	2405	2410	B-Pathological_formation
cell	2411	2415	I-Pathological_formation
carcinomas	2416	2426	I-Pathological_formation
by	2427	2429	O
regulating	2430	2440	O
angiogenesis	2441	2453	O
and	2454	2457	O
/	2457	2458	O
or	2458	2460	O
lymphangiogenesis	2461	2478	O
.	2478	2479	O

The	2480	2483	O
study	2484	2489	O
shows	2490	2495	O
that	2496	2500	O
clear	2501	2506	B-Pathological_formation
cell	2507	2511	I-Pathological_formation
tumors	2512	2518	I-Pathological_formation
are	2519	2522	O
able	2523	2527	O
to	2528	2530	O
up	2531	2533	O
-	2533	2534	O
regulate	2534	2542	O
angiogenic	2543	2553	O
growth	2554	2560	O
factor	2561	2567	O
receptors	2568	2577	O
more	2578	2582	O
efficiently	2583	2594	O
than	2595	2599	O
chromophil	2600	2610	B-Pathological_formation
(	2611	2612	O
papillary	2612	2621	B-Pathological_formation
)	2621	2622	O
,	2622	2623	O
that	2624	2628	O
clear	2629	2634	B-Pathological_formation
cell	2635	2639	I-Pathological_formation
tumors	2640	2646	I-Pathological_formation
can	2647	2650	O
use	2651	2654	O
pathways	2655	2663	O
independent	2664	2675	O
of	2676	2678	O
VHL	2679	2682	B-Gene_or_gene_product
to	2683	2685	O
regulate	2686	2694	O
angiogenesis	2695	2707	O
,	2707	2708	O
and	2709	2712	O
that	2713	2717	O
this	2718	2722	O
combined	2723	2731	O
regulation	2732	2742	O
may	2743	2746	O
account	2747	2754	O
for	2755	2758	O
their	2759	2764	O
more	2765	2769	O
aggressive	2770	2780	O
phenotype	2781	2790	O
,	2790	2791	O
which	2792	2797	O
suggests	2798	2806	O
that	2807	2811	O
targeting	2812	2821	O
VEGFR1	2822	2828	B-Gene_or_gene_product
(	2829	2830	O
flt	2830	2833	B-Gene_or_gene_product
-	2833	2834	I-Gene_or_gene_product
l	2834	2835	I-Gene_or_gene_product
)	2835	2836	O
may	2837	2840	O
be	2841	2843	O
particularly	2844	2856	O
effective	2857	2866	O
in	2867	2869	O
these	2870	2875	O
tumor	2876	2881	B-Pathological_formation
types	2882	2887	O
.	2887	2888	O

